Effect of an immune enhancer, GPI-0100, on vaccination with live attenuated herpes simplex virus (HSV) type 2 or glycoprotein D on genital HSV-2 infections of guinea pigs

Antiviral Research

Volumn 80, Issue 2, 2008, Pages 223-224

  Quenelle, Debra C ^a   Collins, Deborah J ^a   Rice, Terri L ^a   Prichard, Mark N ^a   Marciani, Dante J ^b   Kern, Earl R ^a  

^a UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

^b HAWAII BIOTECH INC   (United States)

Author keywords

AD 472; gD2; GPI 0100; Guinea pigs; Herpes; HSV 2; Vaccine

Indexed keywords

AD 472; GLYCOPROTEIN D; GPI 0100; HERPES VACCINE; SAPONIN DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG POTENTIATION; FEMALE; GENITAL HERPES; GUINEA PIG; HERPES SIMPLEX VIRUS 2; IMMUNIZATION; NONHUMAN; PRIORITY JOURNAL; VACCINATION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; FEMALE; GUINEA PIGS; HERPES GENITALIS; HERPES SIMPLEX VIRUS VACCINES; HERPESVIRUS 2, HUMAN; HUMANS; SAPONINS; VACCINATION; VACCINES, ATTENUATED; VIRAL ENVELOPE PROTEINS;

ANIMALIA; CAVIA; HERPES; HUMAN HERPESVIRUS 2; QUILLAJA;

EID: 53249115473     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.antiviral.2008.05.011     Document Type: Article

References (5)

1. Prichard M.N., Kaiwar R., Jackman W.T., Quenelle D.C., Collins D.J., Kern E.R., Kemble G.M., and Spaete R.R. Evaluation of AD472, a live attenuated recombinant herpes simplex virus type 2 vaccine in guinea pigs. Vaccine 23 (2005) 5424-5431
2. Quenelle D.C., Collins D.J., Marciani D.J., and Kern E.R. Effect of immunization with herpes simplex virus type-1 (HSV-1) glycoprotein D (gD) plus the immune enhancer GPI-0100 on infection with HSV-1 or HSV-2. Vaccine 24 (2006) 1515-1522
3. Straus S.E., Corey L., Burke R.L., Savarese B., Barnum G., Krause P.R., Kost R.G., Meier J.L., Sekulovich R., Adair S.F., and Dekker C.L. Placebo-controlled trial of vaccination with recombinant glycoprotein D of herpes simplex virus type 2 for immunotherapy of genital herpes. Lancet 343 (1994) 1460-1463
4. Stanberry L.R., Spruance S.L., Cunningham A.L., Bernstein D.I., Mindel A., Sacks S., Tyring S., Aoki F.Y., Slaoui M., Denis M., Vandepapeliere P., and Dubin G. Glycoprotein-D-adjuvant vaccine to prevent genital herpes. N. Engl. J. Med. 347 (2002) 1652-1661
5. Stanberry L.R., and Rosenthal S.L. Progress in vaccines for sexually transmitted diseases. Infect. Dis. Clin. North Am. 19 (2005) 477-490